Skip to content

The Effectiveness of with Morphine, Ketorolac, and Bupivacaine Following upper limb fracture in children: A Randomized Controlled Trial

The Effectiveness of with Morphine, Ketorolac, and Bupivacaine Following upper limb fracture in children: A Randomized Controlled Trial

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220506004
Enrollment
64
Registered
2022-05-06
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children age 1-15 years who will undergo upper limb pain score pediatric upper limb surgery

Interventions

0.25% Bupivacaine 0.5 ml/kg,0.25% Bupivacaine 0.5 ml/kg, Morphine 0.05 mg/kg and Ketorolac 0.5 mg/kg
Active Comparator Drug,Active Comparator Drug
group 1,group 2

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
7 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1) pediatric patient age 7-15 2) bony surgery of upper extremity 3) operated by team of pediatric orthopedists 4) inform consent was completed

Exclusion criteria

Exclusion criteria: loss of sensation eg. neurodeficit abnormal coagulation allergy to NSAIDs, bupivacaine, morphine, or paracetamol eGFR< 90 mL/min/1.73 m2

Design outcomes

Primary

MeasureTime frame
morphine consumption 48 hours postoperative Total morphine consumption (mg)

Secondary

MeasureTime frame
pain score Every 4 hours postoperative until 48 hours pain score

Countries

Thailand

Contacts

Public Contactperajit eamsobhana

siriraj hospital

peerajite@gmail.com0896743554

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026